All systems operational
Q2 2022

Acquired hemophilia A (AHA): underreported, underdiagnosed, undertreated medical condition

Doaa M. El Demerdash · Alia Ayad · Noha Tawfik
10.1186/s43162-021-00074-9 385 Views 8 Citations
8
Citations
385
Views
Abstract

Abstract
Background
Acquired hemophilia A (AHA) is a rare acquired bleeding disorder occurred due to the formation of inhibitory antibodies neutralizing endogenous factor VIII.

Main body
About half the cases are idiopathic. Symptoms include severe and unexpected bleeding that could be life-threatening. High index of suspicion should be raised when unexplained subcutaneous or post-surgical bleeding with isolated prolonged APTT.

Conclusions
Acquired hemophilia A is a rare underdiagnosed underreported acquired hemostatic disorder that presents with sudden usually life-threatening bleeding; it is crucial to raise awareness and suspicion index of clinicians for early diagnosis and treatment to avoid morbidity and mortality.

Cite this Article (APA)
Doaa, M. E. D., Alia, A., Noha, T. (2022). Acquired hemophilia A (AHA): underreported, underdiagnosed, undertreated medical condition. The Egyptian Journal of Internal Medicine. https://doi.org/10.1186/s43162-021-00074-9
Related Papers
Antiangiogenic role of natural flavonoids and their molecular mechanism: an update
Gowtham Kumar Subbaraj; Yasam Santhosh Kumar; Langeswaran Kulanthaivel · 2021
34
cites
391
Bridging autoinflammatory and autoimmune diseases
Emad M. El-Shebiny; Enas S. Zahran; Sabry A. Shoeib; Eman S. Habib · 2021
30
cites
390
Factors affecting glycemic control among Egyptian people with diabetes attending primary health care…
Mai Mohamed Azzam; Adel Alwehedy Ibrahim; Mohammed I. Abd El-Ghany · 2021
27
cites
394
A narrative review of pox: smallpox vs monkeypox
Samiksha Jayswal; Jagdish Kakadiya · 2022
23
cites
390
Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically venti…
Mohammed Abdel Monem Saeed; Alaa Hussein Mohamed; Ahmed Hassan Owaynat · 2022
20
cites
394
Access
View Full Text via DOI
Published in
ISSN 1110-7782
Quartile Q2
AMS Score 94
Field Medicine & Health Sciences
Publisher Springer (Biomed Central Ltd.)
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2022
Language English
Added 14 Aug 2026